BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32346298)

  • 1. The lncRNA LINC01194/miR-486-5p Axis Facilitates Malignancy in Non-Small Cell Lung Cancer via Regulating CDK4.
    Xing Z; Zhang Z; Gao Y; Zhang X; Kong X; Zhang J; Bai H
    Onco Targets Ther; 2020; 13():3151-3163. PubMed ID: 32346298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAX5-induced upregulation of LINC01194 exerts oncogenic properties by regulating GOLPH3 expression via miR-486-5p in prostate cancer.
    Song HR; Guo XB; Duan Y; Meng HY; Wang ZY
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2528-2541. PubMed ID: 33829439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA PART1 promotes cell proliferation and progression in non-small-cell lung cancer cells via sponging miR-17-5p.
    Chen Y; Zhou X; Huang C; Li L; Qin Y; Tian Z; He J; Liu H
    J Cell Biochem; 2021 Apr; 122(3-4):315-325. PubMed ID: 33368623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Lnc LINC00461/miR-30a-5p facilitates progression and malignancy in non-small cell lung cancer via regulating ZEB2.
    Li X; Liu J; Liu M; Xia C; Zhao Q
    Cell Cycle; 2020 Apr; 19(7):825-836. PubMed ID: 32106756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
    He Y; Jiang X; Duan L; Xiong Q; Yuan Y; Liu P; Jiang L; Shen Q; Zhao S; Yang C; Chen Y
    Mol Cancer; 2021 Dec; 20(1):156. PubMed ID: 34856993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA LINC01194 promotes the proliferation, migration and invasion of lung adenocarcinoma cells by targeting miR-641/SETD7 axis.
    Meng F; Zhou Y; Dong B; Dong A; Zhang J
    Cancer Cell Int; 2020 Dec; 20(1):588. PubMed ID: 33372601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome-transferred hsa_circ_0014235 promotes DDP chemoresistance and deteriorates the development of non-small cell lung cancer by mediating the miR-520a-5p/CDK4 pathway.
    Xu X; Tao R; Sun L; Ji X
    Cancer Cell Int; 2020 Nov; 20(1):552. PubMed ID: 33292236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA NR2F2-AS1 induces epithelial-mesenchymal transition of non-small cell lung cancer by modulating BVR/ATF-2 pathway via regulating miR-545-5p/c-Met axis.
    Liu C; Li QG; Zhou Y; Cao YY; Wei ZX; Jin YH; Wang X; Chen YY; Qi L; Geng JX; Liu F
    Am J Cancer Res; 2021; 11(10):4844-4865. PubMed ID: 34765296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lncRNA PCAT6 promotes non-small cell lung cancer cell proliferation, migration and invasion through regulating miR-330-5p.
    Cui LH; Xu HR; Yang W; Yu LJ
    Onco Targets Ther; 2018; 11():7715-7724. PubMed ID: 30464520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA
    Zhang Y; Ma H
    J Thorac Dis; 2023 Mar; 15(3):1289-1301. PubMed ID: 37065560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hsa_circ_0003176 Suppresses the Progression of Non-Small-Cell Lung Cancer via Regulating miR-182-5p/RBM5 Axis.
    Yang F; Pei Y; Xu W; Rong L
    Dis Markers; 2022; 2022():8402116. PubMed ID: 36193508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA MIR155HG knockdown suppresses cell proliferation, migration and invasion in NSCLC by upregulating TP53INP1 directly targeted by miR-155-3p and miR-155-5p.
    Ren XY; Han YD; Lin Q
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4822-4835. PubMed ID: 32432745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of Long Non-Coding RNA
    Zhan Y; Abuduwaili K; Wang X; Shen Y; Nuerlan S; Liu C
    Cancer Manag Res; 2020; 12():7725-7737. PubMed ID: 32943921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of lncRNA LINC01194 in hepatocellular carcinoma via the miR-655-3p/SMAD family member 5 axis.
    Liu Y; Liu J; Cui J; Zhong R; Sun G
    Bioengineered; 2022 Jan; 13(1):1115-1125. PubMed ID: 34978464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA PCAT7 promotes non-small cell lung cancer progression by activating miR-486-5p/CDK4 axis-mediated cell cycle.
    Geng W; Qiu M; Zhang D; Li P; Sun G; Zhou X
    Am J Transl Res; 2022; 14(5):3003-3016. PubMed ID: 35702078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MEG8 promotes NSCLC progression by modulating the miR-15a-5p-miR-15b-5p/PSAT1 axis.
    Guo K; Qi D; Huang B
    Cancer Cell Int; 2021 Feb; 21(1):84. PubMed ID: 33526036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA CYTOR promotes pancreatic cancer cell proliferation and migration by sponging miR-205-5p.
    Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
    Pancreatology; 2020 Sep; 20(6):1139-1148. PubMed ID: 32732173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC01207 promotes the progression of non-small cell lung cancer via regulating ARHGAP11A by sponging miR-525-5p.
    Zhang B; Jin Z; Zhang H
    Cancer Biomark; 2022; 33(3):401-414. PubMed ID: 34487020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA LINC00473 promotes proliferation, migration, invasion and inhibition of apoptosis of non-small cell lung cancer cells by acting as a sponge of miR-497-5p.
    Xu SH; Bo YH; Ma HC; Zhang HN; Shao MJ
    Oncol Lett; 2021 Jun; 21(6):429. PubMed ID: 33868467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HNRNPA2B1-mediated m
    Li K; Gong Q; Xiang XD; Guo G; Liu J; Zhao L; Li J; Chen N; Li H; Zhang LJ; Zhou CY; Wang ZY; Zhuang L
    J Transl Med; 2023 Jun; 21(1):382. PubMed ID: 37308993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.